drospirenone + metionac

This is a **combination drug** containing **drospirenone**, a synthetic progestin, and **Metionac**, a combination product that includes **S-adenosylmethionine** (SAMe), **N-acetylcysteine** (NAC), **alpha-lipoic acid**, and **vitamin B6**. Drospirenone acts as a **progestin**, providing antiandrogenic and antimineralocorticoid effects, and is widely used for contraception, treatment of symptoms related to polycystic ovary syndrome (PCOS), and other hormonal imbalances. Metionac, as a supplement combination, is aimed at modulating **metabolic and endocrine parameters**, potentially offering antioxidant, hepatoprotective, and metabolic support. The drospirenone + metionac combination has been clinically studied for use in **PCOS** in women, in a regimen where oral contraceptive drospirenone is co-administered with Metionac[3]. This combination leverages drospirenone’s hormonal regulation on ovulation and androgen signals, while Metionac is presumed to support metabolic health and oxidative balance, particularly for patients with PCOS who often experience metabolic dysfunction. The **mechanism of action** for drospirenone involves **progesterone receptor agonism**, **mineralocorticoid receptor antagonism**, and **androgen receptor antagonism**[2][4]. Metionac’s action is based on the biological properties of its ingredients: SAMe as a methyl donor and mood modulator, NAC as a glutathione precursor and antioxidant, alpha-lipoic acid as an antioxidant and metabolic cofactor, and vitamin B6 as a key enzyme cofactor in metabolism.